CXCL10 and neoplasm: However, IP-10 can also act the opposite way, when autocrine secretion and CXCL10/CXCR3 signaling by cancer cells support tumor cell proliferation, angiogenesis, and metastasis [17], inhibiting cancer cells’ apoptosis and immune response.